Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 4042 | 343.755 |
09:36 ET | 1300 | 345.2175 |
09:38 ET | 1421 | 346.46 |
09:39 ET | 209 | 347.21 |
09:41 ET | 200 | 346.96 |
09:43 ET | 300 | 346.9571 |
09:45 ET | 835 | 347.03 |
09:48 ET | 3164 | 346.9 |
09:50 ET | 418 | 347.315 |
09:52 ET | 100 | 347.005 |
09:56 ET | 700 | 347.115 |
09:57 ET | 332 | 347.11 |
09:59 ET | 574 | 347.12 |
10:01 ET | 1000 | 347.14 |
10:03 ET | 970 | 346.81 |
10:06 ET | 101 | 347.245 |
10:08 ET | 200 | 347.25 |
10:10 ET | 747 | 347.09 |
10:12 ET | 2027 | 347.44 |
10:14 ET | 1100 | 348.8 |
10:19 ET | 300 | 349.07 |
10:21 ET | 400 | 349.355 |
10:24 ET | 1016 | 350 |
10:26 ET | 200 | 349.885 |
10:28 ET | 1900 | 349.315 |
10:32 ET | 108 | 349.315 |
10:35 ET | 100 | 350.38 |
10:37 ET | 112 | 349.57 |
10:39 ET | 1200 | 350.33 |
10:42 ET | 1227 | 350.34 |
10:46 ET | 400 | 350.28 |
10:48 ET | 6784 | 350.892 |
10:50 ET | 5291 | 352.37 |
10:51 ET | 792 | 352.76 |
10:53 ET | 4277 | 353.31 |
10:55 ET | 3113 | 353.065 |
10:57 ET | 400 | 353.2755 |
11:00 ET | 3614 | 352.43 |
11:02 ET | 1058 | 351.69 |
11:04 ET | 1610 | 352.42 |
11:06 ET | 200 | 352.22 |
11:09 ET | 623 | 352.575 |
11:11 ET | 433 | 352.455 |
11:13 ET | 1381 | 352.305 |
11:18 ET | 1130 | 351.63 |
11:20 ET | 686 | 351.93 |
11:22 ET | 168 | 351.955 |
11:24 ET | 100 | 351.96 |
11:26 ET | 1212 | 352.62 |
11:27 ET | 1255 | 352.78 |
11:31 ET | 300 | 353.09 |
11:38 ET | 1353 | 352.42 |
11:40 ET | 100 | 352.57 |
11:42 ET | 1000 | 352.25 |
11:45 ET | 342 | 352.46 |
11:47 ET | 155 | 352.3962 |
11:49 ET | 775 | 352.42 |
11:51 ET | 500 | 352.43 |
11:58 ET | 1799 | 351.97 |
12:02 ET | 100 | 351.955 |
12:05 ET | 100 | 352.17 |
12:07 ET | 100 | 352.18 |
12:09 ET | 467 | 352.185 |
12:12 ET | 922 | 351.86 |
12:14 ET | 100 | 351.98 |
12:16 ET | 100 | 351.97 |
12:18 ET | 200 | 352.12 |
12:20 ET | 100 | 352.23 |
12:21 ET | 100 | 352.25 |
12:23 ET | 400 | 352.335 |
12:25 ET | 700 | 352.355 |
12:27 ET | 800 | 352.275 |
12:30 ET | 2878 | 351.975 |
12:32 ET | 1891 | 351.29 |
12:34 ET | 209 | 351.29 |
12:36 ET | 600 | 351.285 |
12:39 ET | 300 | 351.3654 |
12:41 ET | 5439 | 350.81 |
12:43 ET | 100 | 350.57 |
12:45 ET | 700 | 350.81 |
12:50 ET | 800 | 350.575 |
12:52 ET | 3060 | 349.83 |
12:54 ET | 350 | 349.5 |
12:56 ET | 600 | 349.8 |
12:57 ET | 300 | 350.09 |
01:01 ET | 200 | 350.035 |
01:03 ET | 128 | 350.005 |
01:06 ET | 733 | 349.945 |
01:08 ET | 396 | 349.68 |
01:10 ET | 600 | 349.63 |
01:12 ET | 200 | 349.7 |
01:15 ET | 200 | 349.595 |
01:19 ET | 100 | 349.885 |
01:21 ET | 1784 | 350.01 |
01:26 ET | 823 | 350.13 |
01:30 ET | 300 | 349.56 |
01:32 ET | 200 | 349.455 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 15.3B | 16.1x | +8.22% |
Biomarin Pharmaceutical Inc | 13.3B | 53.4x | --- |
Exact Sciences Corp | 12.8B | -71.0x | --- |
Neurocrine Biosciences Inc | 12.3B | 36.8x | +62.04% |
Medpace Holdings Inc | 11.1B | 33.6x | +35.10% |
Qiagen NV | 10.4B | 144.5x | +12.66% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.3B |
---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.58 |
EPS | $21.75 |
Book Value | $127.23 |
P/E Ratio | 16.1x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | 13.6x |
Operating Margin | 48.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.